Evidence map›Paper›PMID 30154151›Full record

ArticleCancer research2018

Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin.

Björn Hiller, Anja Hoppe, Christa Haase, Christina Hiller, Nadja Schubert, Werner Müller, Martin A M Reijns, Andrew P Jackson, Thomas A Kunkel, Jörg Wenzel and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Ribonucleotide incorporation into DNA during DNA replication and its consequences.Critical reviews in biochemistry and molecular biology · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Björn Hiller *Institute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Anja Hoppe *Institute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Christa HaaseInstitute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Christina HillerInstitute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Nadja SchubertInstitute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Werner MüllerFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.ORCID 0002-1297-9725
Martin A M ReijnsMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, United Kingdom.ORCID 0002-5048-2752
Andrew P JacksonMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, United Kingdom.
Thomas A KunkelGenome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), NIH, Research Triangle Park, North Carolina.
Jörg WenzelDepartment of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany.ORCID 0002-4744-5993
Rayk Behrendt *Institute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. axel.roers@tu-dresden.de rayk.behrendt@tu-dresden.de.ORCID 0002-1091-2877
Axel Roers *Institute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. axel.roers@tu-dresden.de rayk.behrendt@tu-dresden.de.
University Hospital Carl Gustav Carus · DEInstitute of Genetics and Cancer · GBManchester Academic Health Science Centre · GBNational Institute of Environmental Health Sciences · USUniversity Hospital Bonn · DE

Funding

Structure-Function Studies Of DNA Replication FidelityZIAES065070 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI KUNKEL, THOMAS A · 2009 to 2025
$30.6M
Intramural NIH HHS Z99 ES999999Medical Research Council MC_PC_U127580972
6 · The paper itself

Abstract

Because of imperfect discrimination against ribonucleoside triphosphates by the replicative DNA polymerases, large numbers of ribonucleotides are incorporated into the eukaryotic nuclear genome during S-phase. Ribonucleotides, by far the most common DNA lesion in replicating cells, destabilize the DNA, and an evolutionarily conserved DNA repair machinery, ribonucleotide excision repair (RER), ensures ribonucleotide removal. Whereas complete lack of RER is embryonically lethal, partial loss-of-function mutations in the genes encoding subunits of RNase H2, the enzyme essential for initiation of RER, cause the SLE-related type I interferonopathy Aicardi-Goutières syndrome. Here, we demonstrate that selective inactivation of RER in mouse epidermis results in spontaneous DNA damage and epidermal hyperproliferation associated with loss of hair follicle stem cells and hair follicle function. The animals developed keratinocyte intraepithelial neoplasia and invasive squamous cell carcinoma with complete penetrance, despite potent type I interferon production and skin inflammation. These results suggest that compromises to RER-mediated genome maintenance might represent an important tumor-promoting principle in human cancer.

Indexed as

DNA RepairAnimalsAutoimmune Diseases of the Nervous SystemCarcinoma, Squamous CellCell ProliferationDNA DamageDNA ReplicationEpidermisHumansInflammationInterferonsKeratinocytesMiceMice, Inbred C57BLMutationNervous System MalformationsInterferonsRibonuclease Hribonuclease HIIRibonucleotides

Identifiers

PMID30154151
PMCPMC6526525
OpenAlexW2889197496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.